CIK 0001841387
- Emerging growth company
Candel Therapeutics, Inc.
Sign in to watch- Ticker
- CADL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522214851
- Phone
- +1 617-916-5445
- Business address
- 117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,160,783
- in 1 filing, $3.2M under 10b5-1 plans
Net −$3,160,783. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-23 | Nabel Gary J. Director | Grant or award · Stock Option (Right to Buy) | +32,000 | 32,000 | ||
| 2025-06-25 | Nabel Gary J. Director | Grant or award | +5,353 | $4.67 | $25K | 5,353 |
| 2025-06-17 | Nabel Gary J. Director | Grant or award · Stock Option (Right to Buy) | +14,240 | 14,240 | ||
| 2024-06-26 | Nabel Gary J. Director | Grant or award · Stock Option (Right to Buy) | +14,240 | 14,240 | ||
| 2023-06-28 | Nabel Gary J. Director | Grant or award · Stock Option (Right to Buy) | +14,240 | 14,240 | ||
| 2022-08-08 | Nabel Gary J. Director | Grant or award · Stock Option (Right to Buy) | +28,480 | 28,480 |
Page 1 of 1 · 6 trades